Literature DB >> 12624628

Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial.

Silvy Laporte1, Sara Quenet, Andréa Buchmüller-Cordier, Jacqueline Reynaud, Brigitte Tardy-Poncet, Christine Thirion, Hervé Decousus, Patrick Mismetti.   

Abstract

The aim of the study was to assess the respective roles of the half-life of elimination of oral anticoagulants and patient education as causes of instability of anticoagulation level in patients on oral anticoagulant therapy. Patients were randomised to receive either warfarin (long half-life) or acenocoumarol (short half-life) and either intensive or standard education, according to a factorial design. Instability of oral anticoagulant therapy was evaluated by the percentage of INRs and the time within the target range, and the variability between successive measurements. Compliance was assessed by means of electronic pill bottles. Eighty-six patients were included. Apart from the variability index, instability was similar between groups. Correlations between compliance and instability were observed only in the acenocoumarol group. No difference was found between the education groups. In patients starting oral anticoagulant therapy, dose determination may be the most important factor contributing to instability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624628

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Authors:  Miney Paquette; Daniel M Witt; Anne Holbrook; Jane Skov; Jack Ansell; Holger J Schünemann; Wojtek Wiercioch; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-05-28

2.  A "two-step" educational approach for patients taking oral anticoagulants does not improve therapy control.

Authors:  Doris Barcellona; Paolo Contu; Francesco Marongiu
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

3.  Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists.

Authors:  Alexia Blesius; Sylvie Chabaud; Michel Cucherat; Patrick Mismetti; Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

6.  EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.

Authors:  Gilles Pernod; José Labarère; Jacqueline Yver; Bernadette Satger; Benoit Allenet; Touffek Berremili; Michèle Fontaine; Guy Franco; Jean Luc Bosson
Journal:  J Gen Intern Med       Date:  2008-06-20       Impact factor: 5.128

7.  Predictors of unstable anticoagulation in African Americans.

Authors:  Larisa H Cavallari; Jonathan L Aston; Kathryn M Momary; Nancy L Shapiro; Shitalben R Patel; Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2008-06-19       Impact factor: 2.300

Review 8.  Warfarin therapy: in need of improvement after all these years.

Authors:  Stephen E Kimmel
Journal:  Expert Opin Pharmacother       Date:  2008-04       Impact factor: 3.889

9.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

10.  Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate.

Authors:  L Bellamy; N Rosencher; Bi Eriksson
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.